MBX Biosciences, Inc. (MBX) insider trading.
In Q3 2026, insiders at MBX Biosciences, Inc. reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $24K.
- Transactions
- 3
- Purchases (P)
- 0
- Sales (S)
- 1
- Net shares, P minus S
- -370
- Insiders
- 3
- Last filed
- 2026-08-05
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Azoulay Salomon | Officer · Chief Medical Officer | 1 | 0 | 1 |
| Hoerter Steven L. | Director, Officer · President and CEO | 1 | 0 | 0 |
| Smither John W | Officer · Chief Financial Officer | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-04 | Azoulay Salomon | S (D) | 370 | $65.77 | 14,399 | Form 4 |
| 2026-08-03 | Hoerter Steven L. | A (A) | 71,000 | $0 | 82,938 | Form 4 |
| 2026-08-03 | Smither John W | A (A) | 28,000 | $0 | 28,000 | Form 4 |
Transaction codes in this quarter
Get MBX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1776111&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · MBX company page · MBX Biosciences, Inc. on SEC.gov
Questions
Are insiders buying or selling MBX Biosciences, Inc. (MBX)?
In Q3 2026, insiders at MBX Biosciences, Inc. reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $24K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these MBX Biosciences, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/mbx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.